17-09-2021 18:15 via newswire.ca

Worldwide Short Bowel Syndrome Industry to 2026 - Development of Short Bowel Syndrome Drugs is at a Nascent Stage Presents Opportunities

DUBLIN, Sept. 17, 2021 /PRNewswire/ -- The "Short Bowel Syndrome Market Research Report by Drug Class (GLP-2, Glutamine, and Growth Hormone), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been...
Read more »